Today: 21 May 2026
XRP price near $1.36 today: tariff confusion and an AI scare keep crypto traders cautious
24 February 2026
2 mins read

XRP price near $1.36 today: tariff confusion and an AI scare keep crypto traders cautious

NEW YORK, February 24, 2026, 12:55 (EST) — Regular session

  • XRP held around $1.36 following a two-day drop, mirroring the broader risk mood.
  • Markets rattled as renewed questions about U.S. tariffs combine with a viral AI “doomsday” scenario.
  • Traders are eyeing both Trump’s State of the Union and Nvidia’s results as the next signals for risk.

XRP hovered near $1.36 on Tuesday, little moved for the session as investors digested mounting U.S. tariff questions and renewed AI-driven volatility shaking up risk markets.

This month, trading action in the token has hinged more on the overall market mood than on crypto news. Investors have been rotating in and out of “risk-on” and “risk-off” trades—that is, moving toward or away from volatile assets. The pace of those shifts has been sharp, and smaller tokens have felt the impact more quickly than bitcoin.

XRP is now hovering close to the bottom of its February range after tumbling for two days straight. Monday saw a 2.9% decline, following Sunday’s 2.6% slide. The token briefly dipped to roughly $1.31 on Tuesday before steadying, according to data.

One factor: Washington’s latest tariff move. The U.S. started enforcing a new 10% global import tariff on Tuesday, though a White House official told Reuters the Trump administration aimed to push that up to 15%. That comes on the heels of last week’s Supreme Court loss over previous tariffs, injecting fresh uncertainty. “Trade uncertainty was unlikely to go away soon,” ING’s global macro chief Carsten Brzeski said. Reuters

A viral report by Citrini Research has shaken markets, projecting an AI-fueled slump that could push unemployment up to 10.2% by 2028. “I would take it seriously, not literally,” said Nick Ferres, chief investment officer at Vantage Point Asset Management, speaking to Reuters. Reuters

Crypto sentiment remained sluggish. Bitcoin slipped 0.5% to around $64,113; ether hovered close to $1,852 with hardly any movement, according to data. Traders noted that XRP and other lesser-known tokens usually track bitcoin when macro headlines hit the wires.

The market’s undercurrents aren’t helping. U.S. spot bitcoin ETFs—products that give investors access to bitcoin through their brokerage accounts—have posted steady outflows this year, according to MarketWatch. “This is a $6.9 billion buying gap from 2025,” CryptoQuant’s research chief Julio Moreno told MarketWatch. MarketWatch

Leverage cuts both ways when the mood shifts. Liquidations—forced selling triggered as leveraged trades unwind—have sped up the latest selloffs, with risk-off sentiment in play, IG analyst Axel Rudolph said Tuesday in a note.

XRP hasn’t had a defining trigger lately, so it often just mirrors broader sentiment. Ripple—the crypto company tied to XRP—remains tangled in a lengthy legal saga with the SEC, a situation that continues to color how bigger players discuss holding the token.

Still, bulls face a clear risk—should the tariff rate climb to 15% and the AI scare trade intensify, investors might continue shedding volatile holdings. That scenario could see bitcoin dragging XRP beneath its latest lows, especially with thin liquidity amplifying those moves more than anticipated.

Market eyes are turning to two upcoming events. Trump will speak to Congress at 9 p.m. ET on Tuesday, and investors want specifics about tariffs and the White House’s take on the economy, Reuters said. Then Nvidia’s earnings hit on Wednesday, a key moment for risk sentiment that’s already bubbling through crypto.

Stock Market Today

  • Clarity Pharmaceuticals Shares Surge 9.33% on ASX Amid Biotech Sector Rally
    May 21, 2026, 10:09 AM EDT. Clarity Pharmaceuticals Ltd (ASX: CU6) shares jumped 9.33% to A$2.76 on May 21, 2026, driven by renewed investor interest in Australian biotech stocks. The stock's rise occurred despite below-average trading volume of 1.41 million shares, indicating limited market conviction. Clarity's market capitalization stands near A$994 million, but the company remains unprofitable with a trailing twelve months (TTM) diluted earnings per share (EPS) of -0.28 AUD and a year-over-year EPS decline of 70.72%. Investors appear hopeful for potential near-term catalysts such as partnering or licensing deals that commonly stimulate mid-cap biotech stocks. The price advance reflects sector sentiment more than fundamental improvement, underscored by the absence of a meaningful price-to-earnings (P/E) ratio due to ongoing losses.

Latest articles

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

21 May 2026
Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion shares react to $100 million quantum funding news in Washington

21 May 2026
Infleqtion shares rose 5.1% premarket Thursday after the U.S. Commerce Department signed a preliminary $100 million funding letter for its neutral-atom quantum computing project, which would also give the government stock in the company. The proposed award, not yet final, is contingent on milestones and approvals. INFQ last traded at $11.18 before the New York open. D-Wave and Rigetti also saw premarket gains.
Meta stock slips as AMD AI chip pact puts spending back in focus ahead of Nvidia earnings
Previous Story

Meta stock slips as AMD AI chip pact puts spending back in focus ahead of Nvidia earnings

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus
Next Story

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus

Go toTop